Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 5, Issue 1, Page 8 (January 2009)


View previous. 11 of 21 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (107 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

Third Drug Approved for Fibromylagia Treatment

ELIZABETH MECHCATIE (Senior Writer), SHERRY BOSCHERT (San Francisco Bureau)

Milnacipran, a norepinephrine-serotonin reuptake inhibitor, has been approved by the Food and Drug Administration for the management of fibromyalgia in adults, the third drug approved for this indication.

PII: S1553-3212(09)70011-1

doi:10.1016/S1553-3212(09)70011-1


View previous. 11 of 21 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.